Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel drug targets and potential combinations in childhood brain tumours

Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany

Novel drug targets and potential combinations in childhood brain tumours ( Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany )

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic...

Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic...

Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

The global control and prevention of cervical cancer caused by HPV

Prof Thomas Broker - University of Alabama, Birmingham, USA

The global control and prevention of cervical cancer caused by HPV ( Prof Thomas Broker - University of Alabama, Birmingham, USA )

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...

Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )

Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA

Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )

Chimeric antigen receptor produces complete responses and long-term persistence...

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

$Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )$

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in...

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA

$Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )$

T cells engineered with chimeric antigen receptor targeting CD19 produce...

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )

Removal of alpha/beta T cells and of CD19 B cells in children With acute...

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )

More from ecancer